Walsh Dennis Leo 4
4 · Deciphera Pharmaceuticals, Inc. · Filed Jan 18, 2024
Insider Transaction Report
Form 4
Walsh Dennis Leo
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-01-16$10.58/sh+4,727$50,004→ 4,727 totalExercise: $14.46Exp: 2034-01-15→ Common Stock (4,727 underlying)
Footnotes (1)
- [F1]These options were issued upon election by the director to receive his cash board retainer fee of $50,000 for the FY 2024 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy. The shares will vest in four substantially equal installments on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024.